Switching from Natural Desiccated Thyroid to a Liquid Formulation of Levothyroxine for Hypothyroidism

Overview

Journal Case Rep Endocrinol

Publisher Wiley

Specialty Endocrinology

Date 2024 Jan 5

PMID 38179415

Authors

Linda Khoshaba

Laurena Patarkatsi

Affiliations

Soon will be listed here.

Abstract

Natural desiccated thyroid (NDT) is a treatment option for many patients with hypothyroidism, but some still exhibit symptoms despite achievement of normal levels of thyroid stimulating hormone (TSH). In this retrospective case series, 13 patients with hypothyroid symptoms were switched from NDT to a liquid formulation of levothyroxine (LT4; Tirosint®-SOL). Laboratory values ≥4 weeks following the switch showed a decrease in TSH levels, maintenance of free triiodothyronine (fT3) levels, and significant increases in free thyroxine (fT4) levels. Patients reported good tolerability, and case summaries are presented for four patients. In summary, this small retrospective case series showed that patients who still had hypothyroid symptoms despite use of NDT can respond well to oral LT4 liquid formulation, including patients who are intolerant of gluten and/or lactose or on hormone replacement therapy or iron supplementation.

References

Kim J, Konkel K, Diak I, Glueck S, MCCulley L . Clinically Significant Hyperthyroidism and Hypothyroidism Following Exposure to Compounded Thyroid Products. Thyroid. 2020; 31(1):143-146. PMC: 7855378. DOI: 10.1089/thy.2020.0544. View

Fallahi P, Ferrari S, Antonelli A . Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study. Endocrine. 2016; 52(3):597-601. DOI: 10.1007/s12020-015-0836-y. View

Guillaume J, SCHUSSLER G, Goldman J . Components of the total serum thyroid hormone concentrations during pregnancy: high free thyroxine and blunted thyrotropin (TSH) response to TSH-releasing hormone in the first trimester. J Clin Endocrinol Metab. 1985; 60(4):678-84. DOI: 10.1210/jcem-60-4-678. View

Jonklaas J, Bianco A, Bauer A, Burman K, Cappola A, Celi F . Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 2014; 24(12):1670-751. PMC: 4267409. DOI: 10.1089/thy.2014.0028. View

Heald A, Premawardhana L, Taylor P, Okosieme O, Bangi T, Devine H . Is there a role for natural desiccated thyroid in the treatment of levothyroxine unresponsive hypothyroidism? Results from a consecutive case series. Int J Clin Pract. 2021; 75(12):e14967. DOI: 10.1111/ijcp.14967. View

Meyer L, Stephens K, Carter C, Pickard W, Johnson P, Eagerton D . Stability and consistency of compounded oral liquid levothyroxine formulations. J Am Pharm Assoc (2003). 2020; 60(6):e168-e172. DOI: 10.1016/j.japh.2020.05.014. View

Vita R, Saraceno G, Trimarchi F, Benvenga S . Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors. J Clin Endocrinol Metab. 2014; 99(12):4481-6. DOI: 10.1210/jc.2014-2684. View

Chaker L, Razvi S, Bensenor I, Azizi F, Pearce E, Peeters R . Hypothyroidism. Nat Rev Dis Primers. 2022; 8(1):30. DOI: 10.1038/s41572-022-00357-7. View

Spindel E, Arnold M, Cusack B, Wurtman R . Effects of caffeine on anterior pituitary and thyroid function in the rat. J Pharmacol Exp Ther. 1980; 214(1):58-62. View

10.

Khan W, van der Gugten G, Holmes D . Thyrotoxicosis due to 1000-fold error in compounded liothyronine: A case elucidated by mass spectrometry. Clin Mass Spectrom. 2021; 11:8-11. PMC: 8620522. DOI: 10.1016/j.clinms.2018.11.003. View

11.

Asamoah E . Levothyroxine sodium oral solution to control thyroid function in a patient with hypothyroidism and celiac disease. Clin Case Rep. 2021; 9(5):e04170. PMC: 8163109. DOI: 10.1002/ccr3.4170. View

12.

Kratzsch J, Fiedler G, Leichtle A, Brugel M, Buchbinder S, Otto L . New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem. 2005; 51(8):1480-6. DOI: 10.1373/clinchem.2004.047399. View

13.

Brancato D, Scorsone A, Saura G, Ferrara L, Di Noto A, Aiello V . Comparison of TSH Levels with Liquid Formulation Versus Tablet Formulations of Levothyroxine in the Treatment of Adult Hypothyroidism. Endocr Pract. 2014; 20(7):657-62. DOI: 10.4158/EP13418.OR. View

14.

Abdalla S, Bianco A . Defending plasma T3 is a biological priority. Clin Endocrinol (Oxf). 2014; 81(5):633-41. PMC: 4699302. DOI: 10.1111/cen.12538. View

15.

Yue C, Scarsi C, Ducharme M . Pharmacokinetics and potential advantages of a new oral solution of levothyroxine vs. other available dosage forms. Arzneimittelforschung. 2012; 62(12):631-6. DOI: 10.1055/s-0032-1329951. View

16.

Du Y, Rayner C, Jones K, Talley N, Horowitz M . Gastrointestinal Symptoms in Diabetes: Prevalence, Assessment, Pathogenesis, and Management. Diabetes Care. 2018; 41(3):627-637. DOI: 10.2337/dc17-1536. View

17.

Benvenga S, Di Bari F, Vita R . Undertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine. Endocrine. 2017; 56(1):138-145. DOI: 10.1007/s12020-017-1244-2. View

18.

Bornikowska K, Gietka-Czernel M, Raczkiewicz D, Glinicki P, Zgliczynski W . Improvements in Quality of Life and Thyroid Parameters in Hypothyroid Patients on Ethanol-Free Formula of Liquid Levothyroxine Therapy in Comparison to Tablet LT4 Form: An Observational Study. J Clin Med. 2021; 10(22). PMC: 8624226. DOI: 10.3390/jcm10225233. View

19.

Dayan C, Panicker V . Management of hypothyroidism with combination thyroxine (T4) and triiodothyronine (T3) hormone replacement in clinical practice: a review of suggested guidance. Thyroid Res. 2018; 11:1. PMC: 5772692. DOI: 10.1186/s13044-018-0045-x. View

20.

Vita R, Di Bari F, Benvenga S . Oral liquid levothyroxine solves the problem of tablet levothyroxine malabsorption due to concomitant intake of multiple drugs. Expert Opin Drug Deliv. 2017; 14(4):467-472. DOI: 10.1080/17425247.2017.1290604. View